Dr. Nirav Shah, a neurologist and health tech innovator, reveals his inspiring journey of transforming patient care with wearable technology. He discusses how his startup integrates FDA-approved devices for remote monitoring, enabling ICU-level care from home. Dr. Shah emphasizes the life-saving potential of wearables in chronic disease management and the significant shift towards proactive healthcare. He shares the challenges of launching a health tech venture and the exciting prospect of tech advancing medicine, setting the stage for a revolutionary future.

Nirav Shah, a founding partner at Versor Investments, joins GARP editorial director Robert Sales to dive into the fascinating intersection of AI and finance. They discuss how AI is reshaping risk management and portfolio optimization in asset management. Shah highlights challenges like bias and data governance, stressing the need for robust regulations. The duo explores the transformative potential of generative AI and predicts significant advancements in investment strategies, drawing parallels to the revolutionary impact of the iPhone on technology.

Tanya Siddiqi and Nirav Shah discuss the role of BTK inhibitors and degraders in NHL. They also explore the growing role of bispecific antibodies in this disease setting. Topics include novel therapies, Perdibrutnib as a non-covalent inhibitor, lessons from a first-in-class bispecific therapy, potential of Biennium-2-M-Amp in DLBCL, and Phase 2 trial findings of Audra Nextermat and Plimotumab.